摘要
本研究旨在探讨Survivin基因在淋巴瘤细胞中的生物学作用,为将来以Survivin为靶点治疗套细胞淋巴瘤提供实验室证据。体外化学合成针对survivin mRNA基因的siRNA片段,通过DMRIE-C转染Jeko-1细胞,以无关siRNA、未转染的细胞为对照,采用RT-PCR和Western blot方法检测siRNA的抑制效果,利用流式细胞术检测细胞的凋亡率,用CCK-8法检测转染24、48、72 h对细胞增殖的影响。结果表明,与未转染的空白组相比,siRNA转染Jeko-1细胞后24、48、72 h survivin mRNA的相对表达量分别为0.49±0.03、0.38±0.02和0.17±0.02;细胞增殖抑制率分别为(31.2±2.1)%、(43.3±3.4)%和(52.6±2.5)%;细胞凋亡率分别为(6.3±0.5)%、(13.5±1.1)%和(23.6±1.6)%;survivin蛋白表达水平逐步减低。结论:靶向survivin的siRNA能在体外特异性下调目的基因survivin mRNA和蛋白的表达,表现出抑制Jeko-1细胞增殖和促使其凋亡的生物学效应,survivin基因有望成为淋巴瘤治疗的一个药物靶点。
This study was aimed to investigate the impact of specific siRNA on survivin gene in transfected lymphoma cell line and provide experimental evidences for future treatment of mantle cell lymphoma. The small interfering RNA(siRNA) targeted survivin mRNA was synthesized in vitro and was transfected into Jeko-1 that showed high survivin expression in mRNA level. The levels of survivin mRNA and protein expression were detected by quantitative reverse transcription polymerase chain reaction(RT-PCR) and Western blot respectively. The apoptosis effect was examined by calculating the ratio of Annexin V-FITC/PI positive cells using flow cytometry. The inhibition of cell proliferation was assayed with CCK-8 reagent after transfection. The results showed that expression of survivin mRNA was markedly suppressed by the siRNA. The relative expression levels were 0.49 ±0.03,0.38 ±0.02 and 0.17 ±0.02 at time points of 24, 48 and 72 h respectively, compared with the control group ; the inhibitive rates of cell proliferation were (31.2 ± 2.1 ) %, (43.3 ±3.4) % and (52.6 ±2.5 ) % ; the apoptotic rates of cells were (6.3 ±0.5 ) %, ( 13.5± 1.1 ) % and (23.6 ± 1.6) % respectively; survivin protein expression levels were gradually reduced. It is concluded that the siRNA targeting survivin down-regulates the expressions of survivin mRNA and protein evidently. The siRNA of survivin displays the potent ability to inhibit the proliferation of lymphoma cell line Jeko-1; survivin may become a ootential molecular target for the therapy of lvmohoma in the future.
出处
《中国实验血液学杂志》
CAS
CSCD
北大核心
2012年第1期88-92,共5页
Journal of Experimental Hematology
基金
国家973项目子课题(编号2010CB529400)
国家自然基金资助项目(编号81010430)